MARIS - TECH LTD (MTEK) Fundamental Analysis & Valuation

NASDAQ:MTEK • IL0011789042

1.8 USD
-0.01 (-0.55%)
At close: Mar 9, 2026
1.6502 USD
-0.15 (-8.32%)
After Hours: 3/9/2026, 8:23:46 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This MTEK fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

1

Taking everything into account, MTEK scores 1 out of 10 in our fundamental rating. MTEK was compared to 124 industry peers in the Electronic Equipment, Instruments & Components industry. MTEK may be in some trouble as it scores bad on both profitability and health. MTEK has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. MTEK Profitability Analysis

1.1 Basic Checks

  • MTEK had negative earnings in the past year.
  • In the past year MTEK has reported a negative cash flow from operations.
  • In the past 5 years MTEK always reported negative net income.
  • In the past 5 years MTEK always reported negative operating cash flow.
MTEK Yearly Net Income VS EBIT VS OCF VS FCFMTEK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -1M -2M -3M -4M -5M

1.2 Ratios

  • MTEK's Return On Assets of -47.00% is on the low side compared to the rest of the industry. MTEK is outperformed by 81.45% of its industry peers.
  • Looking at the Return On Equity, with a value of -106.92%, MTEK is doing worse than 86.29% of the companies in the same industry.
Industry RankSector Rank
ROA -47%
ROE -106.92%
ROIC N/A
ROA(3y)-21.36%
ROA(5y)-43.71%
ROE(3y)-32.99%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MTEK Yearly ROA, ROE, ROICMTEK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 100 -100 -200 -300

1.3 Margins

  • Looking at the Gross Margin, with a value of 46.91%, MTEK is in the better half of the industry, outperforming 79.84% of the companies in the same industry.
  • In the last couple of years the Gross Margin of MTEK has grown nicely.
  • The Profit Margin and Operating Margin are not available for MTEK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 46.91%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.44%
GM growth 5Y5.71%
MTEK Yearly Profit, Operating, Gross MarginsMTEK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. MTEK Health Analysis

2.1 Basic Checks

  • MTEK does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for MTEK has been increased compared to 1 year ago.
  • The number of shares outstanding for MTEK has been increased compared to 5 years ago.
  • Compared to 1 year ago, MTEK has an improved debt to assets ratio.
MTEK Yearly Shares OutstandingMTEK Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2M 4M 6M
MTEK Yearly Total Debt VS Total AssetsMTEK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

  • Based on the Altman-Z score of -1.23, we must say that MTEK is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of MTEK (-1.23) is worse than 80.65% of its industry peers.
  • MTEK has a Debt/Equity ratio of 0.68. This is a neutral value indicating MTEK is somewhat dependend on debt financing.
  • MTEK's Debt to Equity ratio of 0.68 is on the low side compared to the rest of the industry. MTEK is outperformed by 82.26% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF N/A
Altman-Z -1.23
ROIC/WACCN/A
WACC8.12%
MTEK Yearly LT Debt VS Equity VS FCFMTEK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M -5M

2.3 Liquidity

  • A Current Ratio of 1.84 indicates that MTEK should not have too much problems paying its short term obligations.
  • The Current ratio of MTEK (1.84) is worse than 63.71% of its industry peers.
  • MTEK has a Quick Ratio of 1.12. This is a normal value and indicates that MTEK is financially healthy and should not expect problems in meeting its short term obligations.
  • MTEK has a worse Quick ratio (1.12) than 70.97% of its industry peers.
Industry RankSector Rank
Current Ratio 1.84
Quick Ratio 1.12
MTEK Yearly Current Assets VS Current LiabilitesMTEK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. MTEK Growth Analysis

3.1 Past

  • MTEK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1078.00%.
  • Looking at the last year, MTEK shows a very negative growth in Revenue. The Revenue has decreased by -51.55% in the last year.
  • MTEK shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 46.85% yearly.
EPS 1Y (TTM)-1078%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1898.8%
Revenue 1Y (TTM)-51.55%
Revenue growth 3Y42.97%
Revenue growth 5Y46.85%
Sales Q2Q%-79.27%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MTEK Yearly Revenue VS EstimatesMTEK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2M 4M 6M

More info and screens

Find the best growth stocksShow best growing peers

0

4. MTEK Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for MTEK. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MTEK Price Earnings VS Forward Price EarningsMTEK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MTEK Per share dataMTEK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MTEK Dividend Analysis

5.1 Amount

  • MTEK does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MTEK Fundamentals: All Metrics, Ratios and Statistics

MARIS - TECH LTD

NASDAQ:MTEK (3/9/2026, 8:23:46 PM)

After market: 1.6502 -0.15 (-8.32%)

1.8

-0.01 (-0.55%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)09-26
Earnings (Next)03-26
Inst Owners10.56%
Inst Owner Change0%
Ins Owners33.92%
Ins Owner ChangeN/A
Market Cap14.36M
Revenue(TTM)3.38M
Net Income(TTM)-3.75M
AnalystsN/A
Price TargetN/A
Short Float %0.26%
Short Ratio0.13
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.26
P/FCF N/A
P/OCF N/A
P/B 4.09
P/tB 4.09
EV/EBITDA N/A
EPS(TTM)-0.47
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.32
FCFYN/A
OCF(TTM)-0.32
OCFYN/A
SpS0.42
BVpS0.44
TBVpS0.44
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -47%
ROE -106.92%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 46.91%
FCFM N/A
ROA(3y)-21.36%
ROA(5y)-43.71%
ROE(3y)-32.99%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.44%
GM growth 5Y5.71%
F-Score2
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 23.35%
Cap/Sales 0.81%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.84
Quick Ratio 1.12
Altman-Z -1.23
F-Score2
WACC8.12%
ROIC/WACCN/A
Cap/Depr(3y)581.87%
Cap/Depr(5y)N/A
Cap/Sales(3y)5.53%
Cap/Sales(5y)3.62%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1078%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1898.8%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-51.55%
Revenue growth 3Y42.97%
Revenue growth 5Y46.85%
Sales Q2Q%-79.27%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-706.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y42.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y39.31%
OCF growth 3YN/A
OCF growth 5YN/A

MARIS - TECH LTD / MTEK FAQ

What is the fundamental rating for MTEK stock?

ChartMill assigns a fundamental rating of 1 / 10 to MTEK.


What is the valuation status for MTEK stock?

ChartMill assigns a valuation rating of 0 / 10 to MARIS - TECH LTD (MTEK). This can be considered as Overvalued.


What is the profitability of MTEK stock?

MARIS - TECH LTD (MTEK) has a profitability rating of 1 / 10.